Skip to search boxSkip to navigationSkip to main content

Role of MicroRNA-141 in the Aging Musculoskeletal System: A Current Overview

*Corresponding author for this work
Scholary Output:
Contribution to journal
Review article
Peer-review

Abstract

MicroRNA's are small non-coding RNAs that regulate the expression of genes by targeting the 3’ UTR's of mRNA. Studies reveal that miRNAs play a pivotal role in normal musculoskeletal function such as mesenchymal stem cell differentiation, survivability and apoptosis, osteogenesis, and chondrogenesis. Changes in normal miRNA expression have been linked to a number of pathological disease processes. Additionally, with aging, it is noted that there is dysregulation in the normal function of stem cell differentiation, bone formation/degradation, chondrocyte function, and muscle degeneration. Due to the change in expression of miRNA in degenerative musculoskeletal pathology, it is believed that these molecules may be at least partially responsible for cellular dysfunction. A number of miRNAs have already been identified to play a role in osteoarthritis, osteoporosis and sarcopenia. One miRNA that has become of interest recently is miRNA 141. The purpose of this article is to review the current literature available on miRNA 141 and how it could play a role in osteoporosis, osteoarthritis and musculoskeletal pathology overall.

Publication Information

Output type

Scholary Output:
Contribution to journal
Review article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 9-15 (7 pages)

Journal (Volume, Issue Number)

Mechanisms of Ageing and Development (Volume 178)

Publication milestones

  • Published - 03/2019

Publication status

Published - 03/2019

ISSN

0047-6374

Publication IDs

  • Scopus: 85058181450
  • PubMed: 30528652

Publication metrics

Metrics

SciVal
FWCI
0.61
SciVal
Author count
7
SciVal
citations
9
SciVal
Paper percentile
87
Scopus
citations
Fractional count
5
Fractional count
0.71
Fractional count
2
Fractional count
0.29
Fractional count
5
Fractional count
1

PlumX, opens in new tab

Captures
32
Citation count
21

Funding Details

This publication is based upon work supported in part by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development Program (VA Merit Award 1I01CX000930 01 , WDH) and the National Institutes of Health ( NIA-AG036675 SF, MH, CS, WDH). The contents of this publication do not represent the views of the Department of Veterans Affairs, or the United States Government. The above mentioned funding did not lead to any conflict of interests regarding the publication of this manuscript. The authors also declare that there is no other conflict of interest regarding the publication of this manuscript.
FundersFunding numbers
Biomedical Laboratory Research and Development Program
-
Veterans Health Administration
-
NIH
-
NIA
P01AG036675
VA
1I01CX000930 01
ORD
-